Post-Transplant Cyclophosphamide and Thymoglobulin, a Graft-Versus-Host Disease Prophylaxis in Matched Sibling Donor Peripheral Blood Stem Cell Transplantations.

Cell Transplant · 2020 · PMC7784589 · PMID 33035116

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Our study showed a trend toward better GRFS and CRFS rates for the PTCy/ATG group than the standard prophylaxis regimen group, but comparable DFS and OS rates.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.